03 Aug 2020 --- European venture company Seventure Partners has revealed that the French government has approved the eligibility of its Health for Life Capital II (HFL 2) fund for microbiome innovation funding. The approval came from the technical committee of the initiative, which was set up to support the financing of technology companies. The move means that HFL 2 will be the first and only microbiome-focused venture part of the program. As part of the initiative, French institutional investors have committed to devote over €5 billion (US$5.8 billion) to the financing of innovative companies by December 31, 2022.
